Gabapentin inhibits the substance P-facilitated K+-evoked release of [3H]glutamate from rat caudal trigeminal nucleus slices

被引:159
作者
Maneuf, YP [1 ]
Hughes, J [1 ]
McKnight, AT [1 ]
机构
[1] Univ Cambridge, Cambridge Labs, Pfizer Global Res & Dev, Cambridge CB2 2QB, England
关键词
gabapentin; substance P; trigeminal nucleus; glutamate;
D O I
10.1016/S0304-3959(01)00316-5
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The effect of gabapentin on the release of the spinal sensory neurotransmitter glutamate has been investigated in an in vitro model using a perfused thin slice preparation from the rat brainstem containing the spinal trigeminal caudal subnucleus (Sp5C) and pre-incubated with [H-3]glutamate. Addition of excess K+ to the perfusing solution increased the content of tritium in the perfusate. The prior addition of substance P increased this index of glutamate release in a concentration-dependent manner, with the mean maximum of around 50% increase obtained at 1-3 muM. The action of substance P to increase the evoked release of glutamate was blocked by the antagonist CP-99994, suggesting a specific involvement of the NK1 receptor in mediating the facilitatory effect. On its own, gabapentin at up to 100 muM did not modify the baseline level of K+-evoked release of glutamate; however, gabapentin caused a concentration-dependent decrease of the facilitatory effect of substance P (EC50 = 6.49 muM). The R-(-)- and S-(+)- isomers of 3-isobutylgaba were then tested against the increase in K+-evoked release of glutamate by substance P. S-(+)-3-isobutylgaba (pregabalin) at 30 muM acted like gabapentin to reduce the substance P-mediated increase of release almost to the baseline level of K+-evoked release, while in contrast the R-(-)-isomer at this concentration produced no reduction, and rather a trend towards a further enhancement of the potentiating effect of substance P. In conclusion, we have found and characterized an effect of gabapentin that is of possible mechanistic relevance to the anti-hyperalgesic/allodynic actions of this compound. (C) 2001 International Association for the Study of Pain. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 35 条
[1]   Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[2]  
Bockbrader Howard N., 1995, Drugs of Today, V31, P613
[3]  
Brodie M J, 1998, Adv Neurol, V76, P223
[4]  
Field MJ, 1997, J PHARMACOL EXP THER, V282, P1242
[5]   Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat [J].
Field, MJ ;
McCleary, S ;
Hughes, J ;
Singh, L .
PAIN, 1999, 80 (1-2) :391-398
[6]   Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents [J].
Field, MJ ;
Oles, RJ ;
Lewis, AS ;
McCleary, S ;
Hughes, J ;
Singh, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) :1513-1522
[7]   The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha(2)delta subunit of a calcium channel [J].
Gee, NS ;
Brown, JP ;
Dissanayake, VUK ;
Offord, J ;
Thurlow, R ;
Woodruff, GN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) :5768-5776
[8]   The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: A c-fos immunocytochemical study [J].
Goadsby, PJ ;
Hoskin, KL .
JOURNAL OF ANATOMY, 1997, 190 :367-375
[9]   MODULATION OF GLUTAMATE RELEASE BY A KAPPA-OPIOID RECEPTOR AGONIST IN RODENT AND PRIMATE STRIATUM [J].
HILL, MP ;
BROTCHIE, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :R1-R2
[10]   NK1 (substance P) receptor antagonists -: why are they not analgesic in humans? [J].
Hill, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (07) :244-246